Trade Report: Today, Israel Chemicals Ltd. (ICL) Posts Earnings Results, Meets Expectations

Today, Israel Chemicals Ltd. (ICL) Posts  Earnings Results, Meets Expectations

Israel Chemicals Ltd. (NYSE:ICL) announced its quarterly earnings data on Wednesday. The company reported $0.09 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.09. The firm had revenue of $1.38 billion for the quarter. Israel Chemicals had a net margin of 7.40% and a return on equity of 17.44%. Israel Chemicals’s quarterly revenue was up .3% compared to the same quarter last year. During the same period last year, the firm earned $0.12 earnings per share.

Israel Chemicals (NYSE:ICL) traded down 2.63% on Friday, reaching $3.70. 38,070 shares of the company were exchanged. The stock has a market capitalization of $4.71 billion, a price-to-earnings ratio of 11.67 and a beta of 1.14. The stock has a 50-day moving average price of $3.74 and a 200 day moving average price of $3.99. Israel Chemicals has a 52 week low of $3.52 and a 52 week high of $5.23.

Several large investors have recently made changes to their positions in the stock. Credit Suisse AG raised its stake in shares of Israel Chemicals by 10.9% in the third quarter. Credit Suisse AG now owns 964,988 shares of the company’s stock worth $3,763,000 after buying an additional 94,506 shares during the last quarter. Scopus Asset Management L.P. purchased a new stake in shares of Israel Chemicals during the third quarter worth $1,949,000. The Manufacturers Life Insurance Company purchased a new stake in shares of Israel Chemicals during the third quarter worth $951,000. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in shares of Israel Chemicals by 32.8% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 99,216 shares of the company’s stock worth $386,000 after buying an additional 24,505 shares during the last quarter. Finally, Nikko Asset Management Americas Inc. raised its stake in shares of Israel Chemicals by 27.6% in the third quarter. Nikko Asset Management Americas Inc. now owns 911,526 shares of the company’s stock worth $3,546,000 after buying an additional 197,243 shares during the last quarter. Institutional investors and hedge funds own 6.51% of the company’s stock.

Separately, Zacks Investment Research upgraded shares of Israel Chemicals from a “sell” rating to a “hold” rating in a research report on Thursday, August 11th.

Related posts

Leave a Comment